Stock report · Delisted · NYSE
Abpro Holdings, Inc. (ABP)
0.52USD Delisted Final close · Feb 20, 2026
ABP no longer trades. Abpro Holdings was delisted from the NYSE in February 2026.
All prices on this page are historical. The last trade was on February 20, 2026, at $0.52.
ABP stock price history
Final trading statistics
- Final close
- $0.52
- Final trading day
- Feb 20, 2026
- Market cap at delisting
- $1.42M
- Shares outstanding
- 2.72M
- Final 52-week range
- $0.16 – $7.34
- Avg. volume (final 3 mo.)
- 1,722,748
- All-time high
- $371.70 · Jul 2024
- All-time low
- $0.52 · Feb 2026
- Return since IPO
- -99.8%
- Beta
- -0.00
- Book value / share
- −$6.04
- Price / book
- -0.09
About Abpro Holdings, Inc.
Abpro Holdings, Inc. was a biotech company working on new antibody designs for cancer immunotherapy and eye disease. Its DiversImmune platform discovered a wide range of antibodies against known and new targets, and its MultiMab platform combined antibody building blocks in various layouts to create full-length multi-specific antibodies.
Lead candidates were ABP-102, a TetraBi antibody targeting HER2 and CD3 for HER2+ solid tumors such as breast and gastric cancer, and ABP-201, a TetraBi antibody blocking both VEGF and ANG-2 for eye diseases including diabetic macular edema and wet age-related macular degeneration. It also developed ABP-110, targeting GPC3 and CD3 for liver cancer, and ABP-150, targeting claudin 18.2 and CD3 for gastric cancer.
The company partnered with Celltrion Inc. and Abpro Bio International, Inc. Incorporated in 2004 and based in Woburn, Massachusetts, it was delisted from the NYSE in February 2026, last trading on February 20, 2026 at $0.52.
- Exchange (former)
- NYSE
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Woburn, MA
- Employees
- 6
- IPO date
- March 9, 2022
- Delisted
- February 20, 2026
- SEC CIK
- 1670356
Abpro financials before the delisting
The last 5 fiscal years Abpro reported as a public company, fiscal year ending December.
ABP revenue and net income
ABP earnings per share
ABP annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $0.00 | −$2.9M | — |
| FY2024 | $183.0K | −$7.2M | −$9.60 |
| FY2023 | $122.0K | −$11.7M | — |
| FY2022 | $2.03M | −$17.2M | — |
| FY2021 | $480.0K | −$14.7M | — |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Abpro stock FAQ
What happened to Abpro stock?
Abpro Holdings was delisted from the NYSE in February 2026. The final close was $0.52 on February 20, 2026.
Can I still buy ABP stock?
No. ABP is no longer listed on the NYSE or any other U.S. exchange; it was removed on February 20, 2026.
What was the last price of ABP?
ABP last closed at $0.52 on February 20, 2026, which valued the company at about $1.42M.
How did Abpro do in its last full fiscal year?
In fiscal 2025, its last full year as a public company, Abpro reported revenue of $0.00 and net income of −$2.9M.
When did Abpro go public?
Abpro shares started trading on March 9, 2022.
ABP no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.